He was named as one of the 50 most influential people on IP issues by Managing IP in 2012.
For individual developers, these entities not only provide needed respite from IP issues but also provide an interesting avenue for how IP policies develop.
Some agencies may have different priorities than IP agencies on IP issues.
He has previously served as a Fulbright Specialist expert on trade and IP issues in India.
As for the "TPP IP issues" e-mail, AdvaMed says that Gunn is simply in the habit of using "TPP IP issues" as a shorthand for all of the issues that he works on, which also includes non-IP issues of interest to medical device companies.
Photograph: KaiChanVong/Some rights reserved If you're having trouble unravelling those gritty IP issues for your all-important business plan, now's your chance to get free, professional advice.
While a small percentage of firms reported having abandoned or not started innovation projects because of IP issues, larger fractions reported having pursued their projects after modifying them.
Indeed, a USTR spokeswoman couldn't name any examples of non-industry public interest advocates who have been cleared to advise USTR on IP issues.
Tools to handle IP issues may include exploitation and technological implementation plans, non-exclusive licensing, patenting, knowledge property rights, and pre-existing know-how.
"Not only do they have a lot of technology to develop, but there will also be IP issues to consider," he says.
On Jan . 22 in an e-mail with the subject line "TPP IP Issues," Gunn wrote that USTR official Probir Mehta "has confirmed a meeting for the following individuals, representing ITAC3 on TPP IP issues". ITAC3 is a USTR advisory committee representing pharmaceutical and medical device companies.
